• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sumo Logic (Nasdaq – SUMO), Angion Biomedica Corp (Nasdaq - ANGN), TravelCenters of America Inc. (Nasdaq - TA), IAA, Inc. (NYSE - IAA)

By: Brodsky & Smith LLC via GlobeNewswire
February 22, 2023 at 10:44 AM EST

BALA CYNWYD, Pa., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

Sumo Logic (Nasdaq – SUMO)

Under the terms of the agreement, Sumo will be acquired by affiliates of Francisco Partners. Sumo stockholders will receive $12.05 per common share at a total expected equity value of approximately $1.7 billion. The investigation concerns whether the Sumo Board breached its fiduciary duties to shareholders by failing to conduct a fair process, and whether Francisco Partners is paying too little for the Company.

Additional information can be found at https://www.brodskysmith.com/cases/sumo-logic-nasdaq-sumo/.

Angion Biomedica Corp (Nasdaq - ANGN)

Under the terms of the deal, Angion will merge with Elicio Therapeutics, a privately-held, clinical-stage biotechnology company. Elicio will merge with a wholly-owned subsidiary of Angion, and stockholders of Elicio will receive newly issued shares of Angion common stock. Current Angion stockholders are expected to own approximately 34.5% of the newly combined company while Elicio stockholders will own 65.5% of the newly combined company. The investigation concerns whether the Angion Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution to Angion shareholders in the combined company.

Additional information can be found at https://www.brodskysmith.com/cases/angion-biomedica-corp-nasdaq-angn/.

TravelCenters of America Inc. (Nasdaq - TA)

Under the terms of the Merger Agreement, TravelCenters will be acquired by BP p.l.c. (NYSE - BP). BP will pay $86.00 in cash for each share of TravelCenters common stock in a deal valued at approximately $1.3 billion. The investigation concerns whether the TravelCenters Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether BP is paying too little for the Company.

Additional information can be found at https://www.brodskysmith.com/cases/travelcenters-america-inc-nasdaq-ta/.

IAA, Inc. (NYSE - IAA)

Under the terms of the Merger Agreement, IAA will be acquired by Ritchie Bros. Auctioneers Incorporated (“Ritchie Bros.”) (NYSE - RBA). Ritchie Bros. will pay $10.00 in cash and 0.5804 shares of Ritchie Bros. common stock (representing $46.88 per share) for each share of IAA common stock in a deal valued at approximately $7.3 billion. The investigation concerns whether the IAA Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Ritchie Bros.is paying too little for the Company. For example, the deal consideration is below the 52-week high of $55.01 for the Company’s shares.

Additional information can be found at https://www.brodskysmith.com/cases/iaa-inc-nyse-iaa/.

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.


Primary Logo

More News

View More
Will Hims & Hers Fall Along With Novo Nordisk?
Today 17:07 EDT
Via MarketBeat
Tickers HIMS NVO
Play It Cool: Why Comfort Systems USA Is a Hidden AI Winner
Today 15:21 EDT
Via MarketBeat
Topics Artificial Intelligence
Tickers FIX META MSFT NVDA
Rocket Lab Reports Next Week: Here’s What Investors Should Know
Today 10:49 EDT
Via MarketBeat
Tickers RKLB
Apple Stock: Big Earnings, Small Move—Time to Buy?
Today 9:25 EDT
Via MarketBeat
Tickers AAPL META MSFT
Amazon's Earnings: What Comes Next and How to Play It
Today 9:10 EDT
Via MarketBeat
Tickers AMZN
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap